Rejuvenate Biomed is a biomedical company researching the biology of aging and applying this knowledge to develop safe and well tolerated drugs that balance core biological processes associated with age-related functional decline.
Location: Belgium, Limburg, Heusden-Zolder
Total raised: $18.14M
Investors 1
| Date | Name | Website |
| - | Vesalius B... | vesaliusbi... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 12.10.2021 | Series B | $18.14M | - |
Mentions in press and media 5
| Date | Title | Description |
| 08.03.2023 | Finding the Fountain of Youth: Meet the Startups Pioneering Longevity Solutions | If technology allowed humanity to live forever in the future, would you take the ticket? We asked our readers recently and were surprised to see the balance tilt towards “No” (60% of respondents). One answer was hidden in a comment from one... |
| 13.05.2022 | Hello, I must be going: Jorge Gomez is Moderna CFO for only a day; As setbacks mount, Inovio’s Joseph Kim chooses the exit ramp | Jorge Gomez → David Meline will have to put his retirement on hold. In one of the more high-profile one-day tenures since Bill Belichick with the New York Jets, Jorge Gomez’s time as CFO at Moderna is over before it started. Gomez h... |
| 12.05.2022 | Rejuvenate appoints life sciences leader Ajit Shetty as Chair of the Board of Directors to guide international ambitions | DIEPENBEEK, BELGIUM, May 12, 2022 /EINPresswire.com/ -- Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing novel combination drugs for age-related diseases, appoints Dr. Ajit Shetty as Chair of the Board of Directors. As a... |
| 29.03.2022 | Rejuvenate Biomed Started a Groundbreaking Clinical Trial and Expands for Future Growth | Rejuvenate Biomed initiated first-of-its-kind clinical trial with a combination drug for age-related diseases. DIEPENBEEK, HEALTH CAMPUS, BELGIUM, March 29, 2022 /EINPresswire.com/ -- Rejuvenate Biomed NV (“Rejuvenate”), a biomedical compan... |
| 12.10.2021 | Rejuvenate Biomed Raises EUR 15.7M in Series B Funding | Rejuvenate Biomed NV, a Heusden-Zolder, Belgium-based biomedical company developing novel combination drugs for age-related diseases, raised EUR 15.7m in Series B funding. The round was led by Rejuveron Life Sciences AG and Luxembourg-based... |